Ana-MariaOrbaiMD
Rheumatology • Baltimore, MDRheumatoid Arthritis & Related, Spondyloarthropathy
Instructor of Medicine, Johns Hopkins University School of Medicine
Dr. Orbai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4940 Eastern Avenue
Asthma and Allergy Center
Baltimore, MD 21224Phone+1 410-550-8089Fax+1 410-550-5601- Is this information wrong?
Education & Training
Johns Hopkins Bloomberg School of Public HealthMHS, Clinical Investigation, 2012 - 2013
Johns Hopkins UniversityFellowship, Rheumatology, 2010 - 2013- Johns Hopkins UniversityFellowship, Rheumatology, 2010 - 2012
Sinai Hospital of BaltimoreResidency, Internal Medicine, 2008 - 2010- Johns Hopkins UniversityResidency, Internal Medicine, 2007 - 2010
- Sinai Hospital of BaltimoreInternship, Internal Medicine, 2007 - 2008
Iuliu Hatieganu University of Medicine and PharmacyClass of 2004
Certifications & Licensure
FL State Medical License 2020 - Present
MD State Medical License 2013 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow American College of Rheumatology
- Jerome L Greene Foundation Scholar Jerome L Greene Foundation, 2018
- Scientist Development Award Rheumatology Research Foundation, 2014
- Join now to see all
Clinical Trials
- A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis Start of enrollment: 2014 Dec 31
- Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo Start of enrollment: 2016 Jun 27
- A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD) Start of enrollment: 2017 Apr 27
- Join now to see all
Publications & Presentations
PubMed
- Characteristics associated with patient-reported treatment success in psoriatic arthritis.Samuel, C., Finney, A., Grieb, S., Prichett, L., Grader-Beck, T., Haque, U., Miller, J., Orbai, A.> ;Rheumatology. 2024 Mar 9
- Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from ...Laura C Coates, Robert Landewé, Iain B McInnes, Philip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, ...> ;RMD Open. 2024 Feb 22
- Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the Nat...Chat, V., Ellebrecht, C., Kingston, P., Gondo, G., Bell, S., Cordoro, K., Desai, S., Duffin, K., Feldman, S., Garg, A., Gelfand, J., Gladman, D., Green, L., Gudjonsson...> ;Journal of the American Academy of Dermatology. 2024 Feb 7
- Join now to see all
Press Mentions
Emerging and Novel Therapeutics in the Management of Psoriatic ArthritisApril 18th, 2022- How Psoriasis and Your Thyroid May Be LinkedNovember 18th, 2023
Professional Memberships
- Member
Other Languages
- Romanian, French
Hospital Affiliations
Johns Hopkins HospitalBaltimore, Maryland
Johns Hopkins Bayview Medical CenterBaltimore, Maryland
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/ana-maria-orbai
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
